Back for its 22nd Annual Edition, this global bio-pharma industry event will address through its programme the main challenges in investment for 2022, partnering and alliance management and prospects for 2023. Key players contribute their insights in panels which cover the macro picture as well as innovation in different therapeutic sectors.

Attend our presentation

Investing in Gene & Cell Therapy Companies

Time: 12:05PM CET
Day: September 21, 2022



  • Michael Rice, SVP, BioConsulting, Head of Advanced Therapeutics and Rare Diseaes, Lumanity

Click here to register!